ACE Report Cover
Low-intensity pulsed ultrasound improves bone healing in delayed unions of the tibia
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Lingua
Download Download Download
Scaricare
Cite this Report Cite this Report Cite this Report
Citare
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Preferiti
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Lingua
Download Download Download
Scaricare
Cite this Report Cite this Report Cite this Report
Citare
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Preferiti
TRAUMA
Low-intensity pulsed ultrasound improves bone healing in delayed unions of the tibia .
Verified
This report has been verified by one or more authors of the original publication.

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2014;2(9):23 BMC Musculoskelet Disord. 2010 Oct 8;11:229. doi: 10.1186/1471-2474-11-229.
Autori che hanno contribuito

MD Schofer JE Block J Aigner A Schmelz

101 patients who had suffered a fracture to the tibial shaft, and for whom delayed union was confirmed were randomized to undergo 16 weeks of active low-intensity pulsed ultrasound (LIPUS) or a sham device, to determine whether LIPUS is effective in promoting bone healing in this population. Results indicated that improvements in bone mineral density (BMD) and gap area at the fracture site were significantly higher in patients treated with LIPUS compared to those treated with a sham device, with a medium degree of effectiveness in patients who completed the protocol. Furthermore, regardless of group allocations, patients whose time since fracture was 48 weeks or more experienced significantly poorer radiological outcomes, compared to fractures experienced <48 weeks prior.


Dettagli sul finanziamento della pubblicazione +
Finanziamento:
Industry funded
Sponsor:
Smith & Nephew (Memphis, TN)
Conflitti:
None disclosed

Rischio di pregiudizio

8/10

Criteri di segnalazione

17/20

Indice di fragilità

N/A

Was the allocation sequence adequately generated?

Was allocation adequately concealed?

Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?

Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?

Blinding Patients: Was knowledge of the allocated interventions adequately prevented?

Was loss to follow-up (missing outcome data) infrequent?

Are reports of the study free of suggestion of selective outcome reporting?

Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?

Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?

Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?

Sì = 1

Incerto = 0,5

Non rilevante = 0

No = 0

La valutazione dei criteri di segnalazione valuta la trasparenza con cui gli autori riportano le caratteristiche metodologiche e sperimentali dello studio all'interno della pubblicazione. La valutazione è suddivisa in cinque categorie che vengono presentate di seguito.

4/4

Randomization

4/4

Outcome Measurements

2/4

Inclusion / Exclusion

4/4

Therapy Description

3/4

Statistics

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

L'Indice di Fragilità è uno strumento che aiuta l'interpretazione dei risultati significativi, fornendo una misura della forza di un risultato. L'Indice di Fragilità rappresenta il numero di eventi consecutivi che devono essere aggiunti a un risultato dicotomico per rendere il risultato non più significativo. Un numero piccolo rappresenta un risultato più debole, mentre un numero grande rappresenta un risultato più forte.

Perché questo studio era necessario ora?

Previous studies have found low-intensity pulsed ultrasound (LIPUS) to be safe and effective in promoting bone healing in numerous long-bone fracture types. This conservative treatment works by promoting osteoblastic activity, leading to subsequent increases in osteoid thickness, mineral apposition rate, as well as bone volume at the edge of new bone formation in these patients. Only a paucity of studies, the majority of which single-arm, have examined its effectiveness in patients with delayed union as opposed to fresh fractures. This study was therefore needed to contribute to the limited body of evidence in this population.

Qual era la domanda di ricerca principale?

Is treatment with low-intensity pulsed ultrasound (LIPUS) for 16 weeks effective in promoting bone healing in patients with a delayed union of a tibial shaft fracture, relative to sham treatment?

Caratteristiche dello studio +
Population:
101 patients who had suffered a fracture to the tibial shaft, and for whom delayed union was confirmed. Delayed union was defined as a lack of clinical and radiological evidence of union, bone reaction, or bone continuity at least 16 weeks post-injury or post-treatment (n=84 completed study protocol)
Intervention:
LIPUS device group: Patients (n=51) received low-intensity pulsed ultrasound (LIPUS) using the Exogen 2000/2000+ (Smith & Nephew GmbH, Schenefeld, Germany) device, 20 minutes/day for 16 weeks. The ultrasound device was set at a frequency of 1.5 MHz, a repetition rate of 1 kHz, a pulse duration of 200 us, and a spatial intensity of 30 mW/cm^2. (Mean age: 42.6 +/- 14.6 years; 29% female)
Comparison:
Sham device group: Patients (n=50) received a sham treatment using an identical device - without emitting acoustic pressure waves - 20 minutes/day for 16 weeks. (Mean age: 45.1 +/- 11.9 years; 18% female)
Outcomes:
The primary outcomes were bone mineral density (BMD) at the fracture site, 2-3 mm proximal and distal to the index site, as well as gap area (assessed by computed tomography [CT]). BMD was measured in Hounsfield units (HUs). Compliance was also measured by the devices.
Methods:
RCT; Multi-Centre (6 sites); Double-blinded (patients & assessors)
Time:
Assessments were performed at 1, 2 and 3 months.
Quali erano i risultati importanti?
  • Based on a descriptive 'completers' analysis (n=84), log BMD increased from baseline to 16 weeks by a mean of 0.87 HU (SD 0.67) in the treatment group and 0.57 HU (SD 0.38) in the control group. This between-group difference was statistically significant in favour of the treatment group (effect size 0.53; 95% CI 0.09, 0.97; p=0.014).
  • Also based on a descriptive 'completers' analysis (n=84), from baseline to 16 weeks, mean changes in log gap area were -0.131 mm^2 (SD 0.072) in the treatment group and -0.097 mm^2 (SD 0.070) in the control group; this between-group difference was statistically significant (effect size -0.47; 95% CI -0.91, -0.03; p=0.034).
  • Multiple imputation analysis revealed an adjusted difference between groups in the mean change in BMD of 122.4 HU (p=0.007). Based on log transformed data, the adjusted mean BMD improvement was also found to be significantly greater in the treatment group (p=0.002).
  • Using multiple imputation analysis, LIPUS was found to have a statistically significant positive effect on bone gap area (based on log transformed data) (p=0.014). A similar finding was observed for untransformed data (p=0.03).
  • Following multiple regression analysis (i.e. including pre-treatment BMD [ratio 0.64], time since fracture of <48 weeks [ratio 1.33], and use of intramedullary nail fixation [ratio 1.23]) the relative effectiveness of the treatment remained significant (p=0.004), with minimal change in magnitude.
  • Mean BMD was 1.33 times higher for patients with a time since fracture <48 weeks compared to 48 weeks or more when LIPUS status was controlled for. Despite these independent findings, a time since injury x study group interaction was not statistically significant (p=0.76), revealing that LIPUS had a significant effect on bone growth whether or not time since fracture was <48 weeks or >48 weeks. Mean BMD was 1.23 times higher for those who received intramedullary nail fixation.
  • At 16 weeks, there was a non-significant trend towards more patients in the treatment group considered "healed" (33/51 or 65%) compared to the control group (23/50 or 46%) (p=0.07).
  • No device-related adverse events were reported.
Che cosa devo ricordare di più?

Improvement in bone mineral density (BMD) and gap area at the fracture site were significantly higher in patients treated with low-intensity pulsed ultrasound (LIPUS) compared to those treated with a sham device, with a medium degree of effectiveness in 'completers'. Furthermore, regardless of group allocations, patients whose time since fracture was 48 weeks or more experienced significantly poorer radiological outcomes compared to patients treated within 48 weeks of fracture.

Come influenzerà l'assistenza ai miei pazienti?

Results from this study support the use of low-intensity pulsed ultrasound (LIPUS) in the treatment of delayed unions of tibial fractures. This study also emphasizes the need for early treatment when delayed unions are suspected. Additional studies with longer follow-ups are needed to confirm the longitudinal effect of this treatment approach.

DISCLAIMER

Il contenuto di questa pagina è solo a scopo informativo e non intende sostituire la consulenza, la diagnosi o il trattamento medico professionale. Se ha bisogno di cure mediche, si rivolga sempre al suo medico o al pronto soccorso più vicino. Le opinioni, le convinzioni e i punti di vista espressi dalle persone sui contenuti presenti in questa pagina non riflettono le opinioni, le convinzioni e i punti di vista di OrthoEvidence.

0 di 4 articoli mensili GRATUITI sbloccati
Ha raggiunto il suo limite di 4 visualizzazioni di articoli gratuiti questo mese

Accesso a OrthoEvidence a soli 1,99 dollari a settimana.

Rimanga in contatto con le ultime prove. Può disdire in qualsiasi momento.
  • Valutazioni critiche dei più recenti studi randomizzati controllati ad alto impatto e delle revisioni sistematiche in ortopedia.
  • Accesso ai contenuti del podcast OrthoEvidence, tra cui collaborazioni con il Journal of Bone and Joint Surgery, interviste con chirurghi di fama internazionale e tavole rotonde su notizie e argomenti ortopedici.
  • Abbonamento a The Pulse, una newsletter bisettimanale basata sulle evidenze scientifiche, progettata per aiutarla a prendere decisioni cliniche migliori.
Upgrade
Close Dialog
Bentornato!
Ha dimenticato la password?
Inizi la sua prova gratuita oggi stesso!

Il suo account sarà affiliato a
e includerà l'accesso gratuito a OrthoEvidence


O
Ha dimenticato la password?

O
Controlli la sua e-mail

Se esiste un account con l'indirizzo e-mail fornito, le verrà inviata un'e-mail di reimpostazione della password. Se non vede l'e-mail, controlli la cartella spam o posta indesiderata.

Per ulteriore assistenza, contatti il nostro team di supporto.

Effettui il login per abilitare questa funzione

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence attivo. Effettui il login o crei un account di prova GRATUITO.

Tradurre il Rapporto ACE

OrthoEvidence utilizza un servizio di traduzione di terze parti per rendere i contenuti accessibili in più lingue. Si prega di notare che, sebbene venga fatto ogni sforzo per garantire l'accuratezza, le traduzioni potrebbero non essere sempre perfette.

Come citare questo documento ACE Report

OrthoEvidence. Low-intensity pulsed ultrasound improves bone healing in delayed unions of the tibia. OE Journal. 2014;2(9):23. Available from: https://myorthoevidence.com/AceReport/Show/low-intensity-pulsed-ultrasound-improves-bone-healing-in-delayed-unions-of-the-tibia

Copiare la citazione
Effettui il login per abilitare questa funzione

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence attivo. Effettui il login o crei un account di prova GRATUITO.

Funzionalità per i membri Premium

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence Premium.

Condividi questo articolo ACE Report